Patents by Inventor Anthony Burgett

Anthony Burgett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of retinaldehyde dehydrogenases and methods of use
    Patent number: 10519108
    Abstract: Compounds having inhibitory activity against retinaldehyde dehydrogenases (RALDHs). The compounds can be used, for example, to inhibit synthesis of retinoic acid for the treatment of refractive error disorders such as myopia, and as infertility treatments by inhibiting spermatogenesis.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: December 31, 2019
    Assignees: The Board of Regents of the University of Oklahoma, Oklahoma Medical Research Foundation
    Inventors: Jody A. Summers, Angelica R. Harper, Tim Mather, Anthony Burgett, Anh Thi Quynh Le
  • INHIBITORS OF RETINALDEHYDE DEHYDROGENASES AND METHODS OF USE
    Publication number: 20180258037
    Abstract: Compounds having inhibitory activity against retinaldehyde dehydrogenases (RALDHs). The compounds can be used, for example, to inhibit synthesis of retinoic acid for the treatment of refractive error disorders such as myopia, and as infertility treatments by inhibiting spermatogenesis.
    Type: Application
    Filed: September 16, 2016
    Publication date: September 13, 2018
    Inventors: Jody A. SUMMERS, Angelica R. HARPER, Tim MATHER, Anthony BURGETT, Anh Thi Quynh LE
  • THIN FILM DOPED ZnO NEUTRON DETECTOR
    Publication number: 20130075718
    Abstract: A neutron detector having a scintillator layer comprising a thin film of doped zinc oxide is disclosed. The use of doped zinc oxide in such applications provides appliances and detectors that are rugged, tolerant to shocks and temperature variations, non-hygoroscopic, and suitable for outdoor applications.
    Type: Application
    Filed: March 20, 2012
    Publication date: March 28, 2013
    Inventors: Jeff E. Nause, Eric Anthony Burgett, Nolan Elmer Hertel, Ian Ferguson
  • Compounds That Bind Oxysterol Binding Proteins, and Methods of Use Thereof
    Publication number: 20110319352
    Abstract: The invention relates in part to the discovery that certain CRAMs, such as schweinfurthin A, target OSBPs (a family of oxysterol binding proteins). Because OSBPs have been shown to be integral to atherosclerosis and Alzheimer's disease (AD), one aspect of the invention relates to the use of CRAMs, or a pharmaceutically acceptable salt, biologically active metabolite, solvate, hydrate, prodrug, enantiomer or stereoisomer thereof, in the treatment and/or prevention of atherosclerosis, Alzheimer's disease and related disorders. Another aspect of the invention relates to novel derivatives of CRAMs, or a pharmaceutically acceptable salt, biologically active metabolite, solvate, hydrate, prodrug, enantiomer or stereoisomer thereof, for the treatment and/or prevention of atherosclerosis, Alzheimer's disease and related disorders. Another aspect of the invention relates to the use of an immobilized CRAMs, such as OSW-I, to aid in screening of compounds to identify additional OSBP binders.
    Type: Application
    Filed: December 11, 2009
    Publication date: December 29, 2011
    Applicant: President and Fellows of Harvard College
    Inventors: Matthew D. Shair, Anthony Burgett, D. Ryan Anderson
  • THIN FILM DOPED ZnO NEUTRON DETECTORS
    Publication number: 20110266448
    Abstract: A neutron detector having a scintillator layor comprising a thin film of doped zinc oxide is disclosed. The use of doped zinc oxide in such applications provides appliances and detectors that are rugged, tolerant to shocks and temperature variations, non-hygoroscopic, and suitable for outdoor applications.
    Type: Application
    Filed: March 17, 2011
    Publication date: November 3, 2011
    Inventors: Eric Anthony BURGETT, Nolan Elmer HERTEL, Jeff E. NAUSE, Ian FERGUSON
  • Diazonamide A analog
    Patent number: 7538129
    Abstract: A specific diazonamide A analog and its salts and conjugates are effective in treating proliferative diseases.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: May 26, 2009
    Assignee: Board of Regents, The University of Texas System
    Inventors: Patrick G. Harran, Noelle Williams, Anthony Burgett
  • Diazonamide a analog
    Publication number: 20070149583
    Abstract: A specific diazonamide A analog and its salts and conjugates are effective in treating proliferative diseases.
    Type: Application
    Filed: October 31, 2006
    Publication date: June 28, 2007
    Inventors: Patrick Harran, Noelle Williams, Anthony Burgett